Company profile for Microvascular Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Microvascular Therapeutics has developed MVT-100, a novel, patented ultrasound contrast agent with neutral surface chemistry. This innovative formulation may serve as a platform for molecular imaging and image-guided therapy. The company has received formal FDA guidance to pursue development through the 505(b)(2) regulatory pathway. An accelerated development strategy has been designed to potentially gain approval for MVT-100 ...
Microvascular Therapeutics has developed MVT-100, a novel, patented ultrasound contrast agent with neutral surface chemistry. This innovative formulation may serve as a platform for molecular imaging and image-guided therapy. The company has received formal FDA guidance to pursue development through the 505(b)(2) regulatory pathway. An accelerated development strategy has been designed to potentially gain approval for MVT-100 in echocardiography, aiming to bring this advanced diagnostic technology to clinical practice efficiently.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1635 East 18th Street, Tucson, AZ 85719
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty